Alivia Kaylor

Danvers

Senior Editor at Pharma News Intelligence

Senior Editor at PharmaLifeScience

Featured in: Favicon

pharmanewsintel.com Favicon

healthitanalytics.com Favicon

techtarget.com

Articles

Moderna's COVID-19 vaccine mNEXSPIKE gains FDA approval

4 days ago | techtarget.com | Alivia Kaylor

Ca-ssis/istock via Getty Images Moderna's next-gen COVID-19 vaccine, mNEXSPIKE, has FDA approval for adults 65+ and high-risk individuals aged 12–64, marking the first approval under revised vaccine guidelines.
FTC targets 200+ Orange Book patents to boost generic drug access

1 week ago | techtarget.com | Alivia Kaylor

Ca-ssis/istock via Getty Images The FTC has issued warning letters to major pharmaceutical companies over more than 200 Orange Book patent listings linked to brand-name drugs that delay generic competition.
RFK Jr. ends COVID-19 vaccines for children, pregnant people

1 week ago | techtarget.com | Alivia Kaylor

Markus Mainka - stock.adobe.com Health Secretary RFK Jr. reverses COVID-19 vaccine recommendations for healthy children and pregnant individuals, sparking concern over vaccination guidance and patient confidence.
FDA framework ends universal COVID-19 booster recommendation

2 weeks ago | techtarget.com | Alivia Kaylor

sdecoret - stock.adobe.com An updated FDA COVID-19 vaccine policy ends universal boosters and requires clinical outcome trials for individuals aged between 6 months and 64 years without risk factors.
Understanding pharmaceutical patent thickets, exclusivity

2 weeks ago | techtarget.com | Alivia Kaylor

Pharmaceutical companies increasingly rely on dense patent thickets, including continuation patents, to delay competition, extend exclusivity and protect profits.
Systemic gaps hinder cell and gene therapy adoption, access

3 weeks ago | techtarget.com | Alivia Kaylor

Over 200 cell and gene therapy treatments could be FDA-approved by 2030, but adoption could lag due to structural barriers, limited infrastructure and centralized access.
How digital twins are reshaping clinical trials

4 weeks ago | techtarget.com | Alivia Kaylor

As drug development costs soar and timelines tighten, AI digital twins help sponsors cut enrollment, speed timelines and improve trial design, while meeting regulatory standards.
FDA reviews oral GLP-1 semaglutide for obesity

1 month ago | techtarget.com | Alivia Kaylor

Ca-ssis/istock via Getty Images Novo Nordisk is pursuing FDA approval for the first oral GLP-1 semaglutide, aiming to expand Wegovy's indication for chronic obesity and weight management.
Biosimilars set to surge as biologic patents expire

1 month ago | techtarget.com | Alivia Kaylor

As key biologics near loss of exclusivity in 2030, biosimilars are expected to deliver major savings and drive $120B in market opportunities across the U.S. healthcare system.
How GLP-1 drug patents worsen healthcare disparities

1 month ago | techtarget.com | Alivia Kaylor

Patent extension strategies and high pricing of GLP-1 drugs reinforce patient access barriers, deepening health inequities while generating massive profits and shareholder returns.